SCHEMBL23927549

SCHEMBL23927549

Cc1cc2c(cc1Nc1cccc(C(C)(C)C)c1)C(C)(C)CCC2(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.41
▸ KCNK18 Q7Z418 1/20 0.40
▸ MAPK14 Q16539 2/20 0.39
▸ CYP26A1 O43174 3/20 0.39
▸ CYP26B1 Q9NR63 2/20 0.39
▸ RXRA P19793 1/20 0.37
▸ RAPGEF4 Q8WZA2 1/20 0.37
▸ ABCG2 Q9UNQ0 1/20 0.36
▸ GRM4 Q14833 1/20 0.36
▸ STK10 O94804 1/20 0.36
▸ SLK Q9H2G2 1/20 0.36
▸ ICMT O60725 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ TEAD1 P28347 2/20 0.35
▸ BUB1 O43683 1/20 0.35
▸ HDAC3 O15379 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ EGFR P00533 1/20 0.34
▸ TNNI3K Q59H18 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23439027 0.85 CYP26A1 (0.46) MAPK14CYP26A1CYP26B1RXRAHDAC3
SCHEMBL26599881 0.83 CYP26A1 (0.36) KIF11MAPK14CYP26A1CYP26B1RXRA
SCHEMBL24772162 0.83 NPSR1 (0.46) BRD4
SCHEMBL23439057 0.80 CYP26A1 (0.39) MAPK14CYP26A1CYP26B1RXRAHDAC3
SCHEMBL23439324 0.80 CYP26A1 (0.42) KIF11MAPK14CYP26A1CYP26B1RXRA
SCHEMBL23439529 0.78 CYP26A1 (0.38) MAPK14CYP26A1CYP26B1RXRAHDAC3
SCHEMBL23444958 0.78 KIF11 (0.41) KIF11CYP26A1RXRAICMTBUB1
SCHEMBL23371572 0.78 CYP26A1 (0.44) CYP26A1CYP26B1RXRAHDAC3HDAC8
SCHEMBL29760994 0.76 GAA (0.37) CYP26A1CYP26B1RXRA
SCHEMBL23927568 0.76 AKR1C3 (0.39) MAPK14CYP26A1CYP26B1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637482-B2 Compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2026-05-26 — — US disclosed
US-12559467-B2 Organic light emitting device LG CHEM, LTD. (KR) 2026-02-24 — — US disclosed
US-20230084250-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-03-16 — — US disclosed
US-20220153758-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-05-19 — — US disclosed
US-20220153758-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-05-19 — — US disclosed
CN-113906581-A Organic light emitting element 株式会社LG化学 2022-01-07 — — CN disclosed
EP-3901158-A2 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG Chem, Ltd. (KR) 2021-10-27 — — EP disclosed
CN-113544136-A Compound and organic light emitting device including the same 株式会社LG化学 2021-10-22 — — CN disclosed
CN-113396151-A Polycyclic compound and organic light-emitting element comprising same 株式会社LG化学 2021-09-14 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637482-B2 Compound and organic light emitting device comprising same NR1H2, NR1H3, NR2E3 KIF11 3421/4885KCNK18 2492/4885MAPK14 4062/4885
US-20220153758-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CCNY, CDYL, NR1H2 KIF11 3997/4885KCNK18 3081/4885MAPK14 4671/4885
US-20230084250-A1 ORGANIC LIGHT EMITTING DEVICE CRY1, CRY2, PER2 KIF11 3610/4885KCNK18 1694/4885MAPK14 4166/4885
US-12559467-B2 Organic light emitting device CRY1, RPS24, ARL1 KIF11 892/4885KCNK18 1869/4885MAPK14 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback